TechConnect Innovation Program

Next generation protein multiplexing

Inanovate, Inc, North Carolina, United States

TECHNOLOGY SUMMARY

Inanovate has developed a new category of protein multiplexing technology called Longitudinal Assay Screening (LAS). The longitudinal process of LAS can be viewed as running multiple sequential fluorescent assays in an automated micro-fluidic environment, generating information on binding kinetics of biomarkers in real-time; delivering a transformative solution to protein multiplexing.

Primary Application Area: Biotech & Biological Sciences

Technology Development Status: Proven Manufacturability

Technology Readiness Level:

FIGURES OF MERIT

Value Proposition:

SHOWCASE SUMMARY

Organization Type: Mid-stage Startup (A or B)

Showcase Booth #: 719

Website: www.inanovate.com

GOVT/EXTERNAL FUNDING SOURCES

Government Funding/Support to Date: